JP2008519128A5 - - Google Patents

Download PDF

Info

Publication number
JP2008519128A5
JP2008519128A5 JP2007540022A JP2007540022A JP2008519128A5 JP 2008519128 A5 JP2008519128 A5 JP 2008519128A5 JP 2007540022 A JP2007540022 A JP 2007540022A JP 2007540022 A JP2007540022 A JP 2007540022A JP 2008519128 A5 JP2008519128 A5 JP 2008519128A5
Authority
JP
Japan
Prior art keywords
integer ranging
bond
daltons
cationic
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007540022A
Other languages
English (en)
Japanese (ja)
Other versions
JP5436779B2 (ja
JP2008519128A (ja
Filing date
Publication date
Priority claimed from US10/981,135 external-priority patent/US8057821B2/en
Application filed filed Critical
Publication of JP2008519128A publication Critical patent/JP2008519128A/ja
Publication of JP2008519128A5 publication Critical patent/JP2008519128A5/ja
Application granted granted Critical
Publication of JP5436779B2 publication Critical patent/JP5436779B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007540022A 2004-11-03 2005-11-03 遺伝子送達用の生分解性架橋カチオン性マルチブロックコポリマーおよびそれを製造する方法 Expired - Fee Related JP5436779B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/981,135 2004-11-03
US10/981,135 US8057821B2 (en) 2004-11-03 2004-11-03 Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
PCT/US2005/039779 WO2006052649A2 (en) 2004-11-03 2005-11-03 Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof

Publications (3)

Publication Number Publication Date
JP2008519128A JP2008519128A (ja) 2008-06-05
JP2008519128A5 true JP2008519128A5 (enExample) 2013-09-05
JP5436779B2 JP5436779B2 (ja) 2014-03-05

Family

ID=36262249

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007540022A Expired - Fee Related JP5436779B2 (ja) 2004-11-03 2005-11-03 遺伝子送達用の生分解性架橋カチオン性マルチブロックコポリマーおよびそれを製造する方法

Country Status (7)

Country Link
US (2) US8057821B2 (enExample)
EP (1) EP1807054A4 (enExample)
JP (1) JP5436779B2 (enExample)
KR (1) KR101208192B1 (enExample)
CN (1) CN101094652B (enExample)
CA (1) CA2585974C (enExample)
WO (1) WO2006052649A2 (enExample)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964571B2 (en) 2004-12-09 2011-06-21 Egen, Inc. Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
PT2730277T (pt) 2004-12-22 2020-04-21 Nitto Denko Corp Veículo de fármaco e kit de veículo de fármaco para a inibição da fibrose
DE102005039154A1 (de) * 2005-08-17 2007-03-01 GÖPFERICH, Achim, Prof. Dr. Bioabbaubare Polymere für den Transport von Nukleinsäuren in Zellen
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
KR100825519B1 (ko) * 2007-01-05 2008-04-25 주식회사 바이오폴리메드 키토산 기재 고분자 접합체 및 그 제조방법
CN106046370A (zh) * 2007-02-28 2016-10-26 塞瑞纳治疗公司 聚噁唑啉poz化合物、合成其的方法、以及靶分子‑poz偶联物
TWI407971B (zh) 2007-03-30 2013-09-11 Nitto Denko Corp Cancer cells and tumor-related fibroblasts
US9078927B2 (en) 2007-07-06 2015-07-14 Cedars-Sinai Medical Center Self-assembling complex for targeting chemical agents to cells
US9144546B2 (en) 2007-08-06 2015-09-29 Clsn Laboratories, Inc. Nucleic acid-lipopolymer compositions
CA2698812A1 (en) 2007-09-14 2009-03-19 Nitto Denko Corporation Drug carriers
US20090130752A1 (en) * 2007-11-07 2009-05-21 University Of Utah Research Foundation Biodegradable poly(disulfide amine)s for gene delivery
US20100285111A1 (en) * 2007-11-09 2010-11-11 Northeastern University Self-assembling micelle-like nanoparticles for systemic gene delivery
US20090171455A1 (en) * 2007-12-31 2009-07-02 Boston Scientific Scimed, Inc. Biodegradable polymers
CN101959934B (zh) * 2008-01-11 2012-12-12 塞瑞纳治疗公司 聚噁唑啉共聚物的多官能形式和包含它的药物组合物
FR2928373B1 (fr) * 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
CA2717370A1 (en) * 2008-03-14 2009-09-17 Egen, Inc. Biodegradable cross-linked branched poly (alkylene imines)
AU2009234266B2 (en) * 2008-04-11 2015-08-06 Tekmira Pharmaceuticals Corporation Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
WO2010085665A2 (en) 2009-01-23 2010-07-29 Cedars-Sinai Medical Center Targeted delivery system
KR101132413B1 (ko) * 2009-05-06 2012-04-03 서울대학교산학협력단 Sars 백신 나노전달체
US8992991B2 (en) 2009-05-15 2015-03-31 The Johns Hopkins University Multicomponent degradable cationic polymers
CN101585921B (zh) * 2009-06-18 2010-12-01 天津大学 温度敏感聚乙烯亚胺-接枝-聚丙烯酸寡乙二醇酯嵌段共聚物及制备方法和应用
CN102575204B (zh) * 2009-10-23 2015-02-25 荷兰联合利华有限公司 染料聚合物
CN101812178B (zh) * 2010-04-20 2012-07-04 武汉大学 还原敏感性聚乙烯亚胺衍生物及其制备方法和应用
RU2012147538A (ru) 2010-05-14 2014-06-20 3Е Сан Продактс Корпорейшн Полимерсодержащие очищающие композиции и способы их получения и применения
RU2013103347A (ru) * 2010-06-25 2014-07-27 Торэй Индастриз, Инк. Водорастворимый полимер и водорастворимый комплекс наночастиц
CA2807552A1 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP3431485B2 (en) 2010-10-01 2024-09-04 ModernaTX, Inc. Engineered nucleic acids and methods of use thereof
CN102174184B (zh) * 2011-01-14 2012-11-21 中国科学院广州生物医药与健康研究院 一种生物可降解的聚合物及其制备方法以及核酸药物运输载体
WO2012135805A2 (en) 2011-03-31 2012-10-04 modeRNA Therapeutics Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
CA2848740A1 (en) 2011-09-16 2013-03-21 Mingxing Wang Amphiphilic cationic polymers for the delivery of therapeutic agents
EP2763701B1 (en) 2011-10-03 2018-12-19 Moderna Therapeutics, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
KR20140102759A (ko) 2011-12-16 2014-08-22 모더나 세라퓨틱스, 인코포레이티드 변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
AU2013243949A1 (en) 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides for the production of biologics and proteins associated with human disease
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9878056B2 (en) 2012-04-02 2018-01-30 Modernatx, Inc. Modified polynucleotides for the production of cosmetic proteins and peptides
DE18200782T1 (de) 2012-04-02 2021-10-21 Modernatx, Inc. Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
CA2820236C (en) 2012-06-15 2022-07-19 The Royal Institution For The Advancement Of Learning/Mcgill University Non-viral nanoparticle-based delivery system
CN104619839A (zh) 2012-08-03 2015-05-13 西塞医疗中心 药物递送蛋白质的增强运输的突变体的分离
CN103305549B (zh) * 2013-06-19 2015-04-22 四川大学 具有多重氧化还原刺激响应的纳米粒子基因载体系统及其制备方法和应用
US9707303B2 (en) 2012-10-10 2017-07-18 Sichuan University Reduction stimulus-responsive gene delivery system and preparation and application thereof
KR101452819B1 (ko) 2012-11-01 2014-10-23 국립암센터 환원제 반응형 이황화물 연결자 함유 고분자-광감각제 결합체 및 이를 포함하는 형광 영상 진단 및 광역학 치료용 조성물
CA2892529C (en) 2012-11-26 2023-04-25 Moderna Therapeutics, Inc. Terminally modified rna
HK1217215A1 (zh) 2013-01-17 2016-12-30 Modernatx, Inc. 用於改变细胞表型的信号传感器多核苷酸
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
WO2014152211A1 (en) 2013-03-14 2014-09-25 Moderna Therapeutics, Inc. Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
DK3019619T3 (da) 2013-07-11 2021-10-11 Modernatx Inc Sammensætninger, der omfatter syntetiske polynukleotider, som koder for crispr-beslægtede proteiner, og syntetiske sgrna'er, og anvendelsesfremgangsmåder
EP3041934A1 (en) 2013-09-03 2016-07-13 Moderna Therapeutics, Inc. Chimeric polynucleotides
US20160194368A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Circular polynucleotides
EA201690675A1 (ru) 2013-10-03 2016-08-31 Модерна Терапьютикс, Инк. Полинуклеотиды, кодирующие рецептор липопротеинов низкой плотности
JP2017500865A (ja) 2013-12-19 2017-01-12 ノバルティス アーゲー レプチンmRNAの組成物および製剤
RU2682335C2 (ru) 2014-01-17 2019-03-19 Сидарс-Синай Медикал Сентр Рецептор-направленные конструкции и их применение
MX2016013025A (es) 2014-04-04 2017-04-27 Cedars Sinai Medical Center Focalizacion de cancer de mama her2+ resistente a trastuzumab con una nanoparticula dirigida de her3.
CN104109248B (zh) * 2014-06-20 2017-02-01 南开大学 基于桥式双环糊精主客体诱导聚集构筑的聚集体及其应用
WO2016011226A1 (en) 2014-07-16 2016-01-21 Moderna Therapeutics, Inc. Chimeric polynucleotides
US20170210788A1 (en) 2014-07-23 2017-07-27 Modernatx, Inc. Modified polynucleotides for the production of intrabodies
CN104356395B (zh) * 2014-11-12 2016-08-17 苏州大学 一种阳离子化丝素蛋白、制备方法及其应用
US10709791B2 (en) 2014-11-12 2020-07-14 University Of Washington Stabilized polymeric carriers for therapeutic agent delivery
CN105012957B (zh) * 2015-07-03 2019-03-22 上海交通大学 一种交联型聚乙烯亚胺作为肿瘤蛋白抗原疫苗载体的用途
US20180256730A1 (en) * 2015-09-16 2018-09-13 University Of Utah Research Foundation A polymeric carrier for delivery of a payload to a cell
DE102017003004A1 (de) * 2017-03-23 2018-09-27 Friedrich-Schiller-Universität Jena Kationische Polymere mit D-Fructose-Substituenten
EP3625345B1 (en) 2017-05-18 2023-05-24 ModernaTX, Inc. Modified messenger rna comprising functional rna elements
WO2018213731A1 (en) 2017-05-18 2018-11-22 Modernatx, Inc. Polynucleotides encoding tethered interleukin-12 (il12) polypeptides and uses thereof
EP3638292A1 (en) 2017-06-14 2020-04-22 ModernaTX, Inc. Polynucleotides encoding coagulation factor viii
EP3679140B1 (en) 2017-09-08 2022-11-16 MiNA Therapeutics Limited Stabilized cebpa sarna compositions and methods of use
US11939601B2 (en) 2017-11-22 2024-03-26 Modernatx, Inc. Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria
WO2019104152A1 (en) 2017-11-22 2019-05-31 Modernatx, Inc. Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
EP3714045A1 (en) 2017-11-22 2020-09-30 Modernatx, Inc. Polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits for the treatment of propionic acidemia
US11802146B2 (en) 2018-01-05 2023-10-31 Modernatx, Inc. Polynucleotides encoding anti-chikungunya virus antibodies
WO2019165583A1 (zh) * 2018-02-27 2019-09-06 苏州大学张家港工业技术研究院 一种可逆自修复环氧树脂及其制备与回收重塑方法
US11566246B2 (en) 2018-04-12 2023-01-31 Mina Therapeutics Limited SIRT1-saRNA compositions and methods of use
US20210148918A1 (en) * 2018-04-17 2021-05-20 Purdue Research Foundation Modifying surface of a live cell and the uses thereof
KR101992236B1 (ko) 2018-05-16 2019-06-24 가톨릭대학교 산학협력단 디셀레노디프로피오네이트의 양 말단에 폴리(입실론-카프로락톤)이 공유결합된 환원분해성 폴리(입실론-카프로락톤) 고분자, 이를 포함하는 항암용 조성물 및 약물 전달용 조성물
EP3796893A1 (en) 2018-05-23 2021-03-31 Modernatx, Inc. Delivery of dna
US20220184185A1 (en) 2018-07-25 2022-06-16 Modernatx, Inc. Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders
EP3833762A4 (en) 2018-08-09 2022-09-28 Verseau Therapeutics, Inc. Oligonucleotide compositions for targeting ccr2 and csf1r and uses thereof
CN110859969B (zh) * 2018-08-28 2022-01-11 上海市第十人民医院 聚乙烯亚胺修饰的荧光素钠造影剂及其制备方法和应用
US20220110966A1 (en) 2018-09-02 2022-04-14 Modernatx, Inc. Polynucleotides encoding very long-chain acyl-coa dehydrogenase for the treatment of very long-chain acyl-coa dehydrogenase deficiency
MA53608A (fr) 2018-09-13 2021-07-21 Modernatx Inc Polynucléotides codant pour les sous-unités e1-alpha, e1-beta et e2 du complexe alpha-cétoacide déshydrogénase à chaîne ramifiée pour le traitement de la leucinose
WO2020056147A2 (en) 2018-09-13 2020-03-19 Modernatx, Inc. Polynucleotides encoding glucose-6-phosphatase for the treatment of glycogen storage disease
CA3112398A1 (en) 2018-09-14 2020-03-19 Modernatx, Inc. Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
US20220152225A1 (en) 2018-09-27 2022-05-19 Modernatx, Inc. Polynucleotides encoding arginase 1 for the treatment of arginase deficiency
WO2020208361A1 (en) 2019-04-12 2020-10-15 Mina Therapeutics Limited Sirt1-sarna compositions and methods of use
EP3965797A1 (en) 2019-05-08 2022-03-16 AstraZeneca AB Compositions for skin and wounds and methods of use thereof
CA3164877A1 (en) * 2019-12-17 2021-06-24 Universiteit Gent Non-viral vectors comprising polypropyleneimine
US20230235298A1 (en) 2020-06-01 2023-07-27 Modernatx, Inc. Phenylalanine hydroxylase variants and uses thereof
AU2021377895A1 (en) 2020-11-13 2023-06-15 Modernatx, Inc. Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
WO2022204380A1 (en) 2021-03-24 2022-09-29 Modernatx, Inc. Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof
US20240207374A1 (en) 2021-03-24 2024-06-27 Modernatx, Inc. Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereof
WO2022204390A1 (en) 2021-03-24 2022-09-29 Modernatx, Inc. Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereof
JP2024512026A (ja) 2021-03-24 2024-03-18 モデルナティエックス インコーポレイテッド オルニチントランスカルバミラーゼ欠損症の治療を目的とした脂質ナノ粒子及びオルニチントランスカルバミラーゼをコードするポリヌクレオチド
WO2022204369A1 (en) 2021-03-24 2022-09-29 Modernatx, Inc. Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia
EP4314292A1 (en) 2021-03-26 2024-02-07 MiNA Therapeutics Limited Tmem173 sarna compositions and methods of use
EP4355882A2 (en) 2021-06-15 2024-04-24 Modernatx, Inc. Engineered polynucleotides for cell-type or microenvironment-specific expression
US20240376445A1 (en) 2021-06-22 2024-11-14 Modernatx, Inc. Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
US20250017867A1 (en) 2021-10-01 2025-01-16 Modernatx, Inc. Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
WO2023099884A1 (en) 2021-12-01 2023-06-08 Mina Therapeutics Limited Pax6 sarna compositions and methods of use
WO2023170435A1 (en) 2022-03-07 2023-09-14 Mina Therapeutics Limited Il10 sarna compositions and methods of use
WO2023183909A2 (en) 2022-03-25 2023-09-28 Modernatx, Inc. Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemia
CN114920859B (zh) * 2022-05-11 2023-09-26 宁夏医科大学总医院 5-氟尿嘧啶-1-丁酰基-β-环糊精第二面衍生物及制备方法及其应用
TW202412818A (zh) 2022-07-26 2024-04-01 美商現代公司 用於暫時控制表現之經工程化多核苷酸
WO2024103225A1 (zh) * 2022-11-14 2024-05-23 林桂孜 一种阳离子聚酯及其制备方法和应用
EP4634388A1 (en) 2022-12-14 2025-10-22 Providence Therapeutics Holdings Inc. Compositions and methods for infectious diseases
WO2024134199A1 (en) 2022-12-22 2024-06-27 Mina Therapeutics Limited Chemically modified sarna compositions and methods of use
WO2024197033A1 (en) 2023-03-21 2024-09-26 Modernatx, Inc. Polynucleotides encoding relaxin for the treatment of heart failure
WO2024229321A1 (en) 2023-05-03 2024-11-07 Modernatx, Inc. Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
WO2025072482A1 (en) 2023-09-27 2025-04-03 Modernatx, Inc. Immunoglobulin a protease polypeptides, polynucleotides, and uses thereof
CN119192568A (zh) * 2024-10-11 2024-12-27 湖北中烟工业有限责任公司 还原敏感型超分子基因载体、其制备方法及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS592464B2 (ja) * 1980-04-16 1984-01-18 電気化学工業株式会社 熱可塑性樹脂組成物
US6359054B1 (en) * 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration
US5733462A (en) * 1996-10-03 1998-03-31 Cytec Technology Corp. Cationic water-soluble polymer precipitation in salt solutions
US6333051B1 (en) * 1998-09-03 2001-12-25 Supratek Pharma, Inc. Nanogel networks and biological agent compositions thereof
JP2002531530A (ja) * 1998-12-04 2002-09-24 カリフォルニア インスティテュート オブ テクノロジー 治療用薬剤を含む超分子錯体
DE19933024C2 (de) * 1999-07-15 2003-03-13 Medinnova Ges Med Innovationen Kationische Blockcopolymere
CN101041079A (zh) * 1999-12-30 2007-09-26 诺瓦提斯公司 用于基因治疗的新的胶体合成载体
US20040142474A1 (en) * 2000-09-14 2004-07-22 Expression Genetics, Inc. Novel cationic lipopolymer as a biocompatible gene delivery agent
US6696038B1 (en) * 2000-09-14 2004-02-24 Expression Genetics, Inc. Cationic lipopolymer as biocompatible gene delivery agent
US6890556B1 (en) * 2001-02-14 2005-05-10 Northwestern University Controlled surface-associated delivery of genes and oligonucleotides
US6652886B2 (en) * 2001-02-16 2003-11-25 Expression Genetics Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
US6521340B2 (en) * 2001-03-15 2003-02-18 Norman B. Rainer Sulfur-containing aliphatic polymer for the selective absorption of dissolved metal species
US7060498B1 (en) * 2001-11-28 2006-06-13 Genta Salus Llc Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
US20030215395A1 (en) * 2002-05-14 2003-11-20 Lei Yu Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
GB0221942D0 (en) * 2002-09-20 2002-10-30 Univ Strathclyde Drug delivery

Similar Documents

Publication Publication Date Title
JP2008519128A5 (enExample)
JP2005532287A5 (enExample)
JP2009521569A5 (enExample)
JP2002531655A5 (enExample)
JP2004532847A5 (enExample)
NO20041459L (no) Kopolymerer for gelatinering av syrer
JP2007532572A5 (enExample)
JP2009521346A5 (enExample)
DE60337004D1 (de) Zusammensetzungen aus kationischen polymeren mit hoher ladungsdichte und konditionierungsmittel
TW200634029A (en) Copolymers and films thereof
JP2005529870A5 (enExample)
ATE308637T1 (de) Adehyde enthaltende polymere als nassfestmittel
WO2007144189A3 (en) Compositions based on hyperbranched condensation polymers and novel hyperbranched condensation polymers
JP2006240292A5 (enExample)
EP1881016A3 (en) Low molecular weight graft copolymers
JP2013500256A5 (enExample)
EP2586842A3 (fr) Fluide de transfert de chaleur
JP2010031199A5 (enExample)
JP2006503143A5 (enExample)
JP2003510400A5 (enExample)
WO2004009135A3 (en) Conjugates of biocompatible polymers with nuclide activation therapy reagents
AU2003218385A8 (en) High molecular weight polymers
JP2015530430A5 (enExample)
JP2004051995A5 (enExample)
JP2011506296A5 (enExample)